Abstract:Objective: To evaluate the predictive value of preoperative peripheral inflammatory markers in patients with vocal fold leukoplakia. Methods: A retrospective study was performed of the patients diagnosed with vocal fold leukoplakia and who accepted carbon dioxide (CO2) laser resection in our center in the last 10 years. We calculated the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) after collecting and analyzing the clinical, histopathological and laboratory data. The potential relation between blood indexes and clinical events as recurrence or canceration was evaluated. Results: A total of 589 patients were involved, including 300 cases without recurrence (group A), 198 with recurrence but not canceration (group B) and 91 transformed into squamous cancer (group C). Baseline analysis of NLR, PLR, and MLR showed no difference among the three groups before the first surgery. But all the indexes significantly elevated in groups B (P < 0.001, < 0.001, 0.023, respectively) and C (P = 0.009, 0.004, 0.007, respectively) in the last operation. The receiver-operating curve (ROC) analysis showed NLR as a potential marker of canceration of leukoplakia (AUC = 0.837) and the cutoff value was 2.505. When regrouping with pathological outcomes, severe dysplasia and squamous cell carcinoma (SCC) groups both revealed a higher level of NLR, PLR, and MLR comparing to the no dysplasia, mild dysplasia, and moderate dysplasia groups. NLR, PLR, and MLR in high-risk group (moderate, severe dysplasia and carcinoma) also elevated comparing to low-risk group (no dysplasia, mild dysplasia) (P = 0.039, 0.011, 0.007, respectively). Conclusions: The peripheral inflammatory markers NLR, PLR, and MLR are closely connected with the development of vocal fold leukoplakia. NLR may be a potential marker to predict the poor outcomes (recurrence or canceration) of patients in first surgery.

Inferior Surface Leukoplakia of Vocal Folds: Risk of Recurrence: A Preliminary Study

I-scan Combined with Laryngovideostroboscopy for Predicting Malignancy in Vocal Fold Leukoplakia

Vocal fold leukoplakia recurrence risk model

Surgery and Proton Pump Inhibitors for Treatment of Vocal Process Granulomas

Analysis of prognostic factors for vocal fold leukoplakia based on 344 cases at a two-year follow up

Recurrence of benign phonotraumatic vocal fold lesions after microlaryngoscopy

The Variation of Peripheral Inflammatory Markers in Vocal Leukoplakia before and after Recurrence and Canceration

Analysis of Surgical Recurrence after Larynx Microsurgery for Benign Lesions

Elevated peripheral inflammatory markers are related with the recurrence and canceration of vocal fold leukoplakia

Recurrence of Vocal Fold Leukoplakia after Carbon Dioxide Laser Therapy

Correlating intraepithelial papillary capillary loops of vocal cord leukoplakia with histopathology

On Prognosis of Recurrence and Canceration After Mucosal Exfoliation for Vocal Cord Leukoplakia

A morphological classification for vocal fold leukoplakia

Genetic polymorphisms and protein levels in vocal fold leukoplakia: a systematic review

Nonsurgical Treatment for Vocal Fold Leukoplakia: an Analysis of 178 Cases

Preliminary Correlation of the Immunoexpression of Cathepsin B and E-Cadherin Proteins in Vocal Fold Leukoplakia

Treatment experience with and clinicopathological analysis of vocal fold leukoplakia per appearance classification guidance: a cohort of 1442 patients

Association between Laryngopharyngeal Reflux and Vocal Fold Leukoplakia

[Clinical analyses of 263 patients with laryngeal leukoplakia]

Candidiasis Causing Vocal Fold Leukoplakia: Review of Clinical and Pathological Results of 289 Cases With Vocal Fold Leukoplakia

Optimal Pathological Prediction of Vocal Fold Leukoplakia Based on IPCLs and Morphology.